【4530】久光製薬

製薬。鎮痛消炎剤。大衆薬も。

東証プライム

医薬品医薬

＞

その他医療・医薬品医他

業績予想修正履歴

{{models[key].tabname}}

決算期	日付	予・実	売上高 (百万円)	対前回	修正率	修正率	営業利益 (百万円)	対前回	修正率	修正率	経常利益 (百万円)	対前回	修正率	修正率	当期利益 (百万円)	対前回	修正率	修正率
2025.02	2024/04/11	当初予	152,000	-	-	-	14,500	-	-	-	18,900	-	-	-	15,800	-	-	-
2024.02	2024/04/11	実	141,706	↑	+0.5%	+7.1%	13,167	↓	-8.6%	+11.6%	19,649	↓	-1.3%	+34.6%	13,969	↓	-4.3%	+31.8%
2024.02	2024/01/11	Q3予	141,000	↑	+6.6%	+6.6%	14,400	↑	+22.0%	+22.0%	19,900	↑	+36.3%	+36.3%	14,600	↑	+37.7%	+37.7%
2024.02	2023/10/06	Q2予	132,300	→	0.0%	0.0%	11,800	→	0.0%	0.0%	14,600	→	0.0%	0.0%	10,600	→	0.0%	0.0%
2024.02	2023/07/13	Q1予	132,300	→	0.0%	0.0%	11,800	→	0.0%	0.0%	14,600	→	0.0%	0.0%	10,600	→	0.0%	0.0%
2024.02	2023/04/13	当初予	132,300	-	-	-	11,800	-	-	-	14,600	-	-	-	10,600	-	-	-
2023.02	2023/04/13	実	128,330	↑	+0.0%	+4.3%	11,599	↑	+0.9%	+4.5%	16,051	↑	+0.3%	+26.4%	11,742	↓	-2.1%	+21.1%
2023.02	2023/03/30	修正予	128,300	↑	+4.3%	+4.3%	11,500	↑	+3.6%	+3.6%	16,000	↑	+26.0%	+26.0%	12,000	↑	+23.7%	+23.7%
2023.02	2023/01/12	Q3予	123,000	→	0.0%	0.0%	11,100	→	0.0%	0.0%	12,700	→	0.0%	0.0%	9,700	→	0.0%	0.0%
2023.02	2022/10/12	Q2予	123,000	→	0.0%	0.0%	11,100	→	0.0%	0.0%	12,700	→	0.0%	0.0%	9,700	→	0.0%	0.0%
2023.02	2022/07/07	Q1予	123,000	→	0.0%	0.0%	11,100	→	0.0%	0.0%	12,700	→	0.0%	0.0%	9,700	→	0.0%	0.0%
2023.02	2022/04/07	当初予	123,000	-	-	-	11,100	-	-	-	12,700	-	-	-	9,700	-	-	-
2022.02	2022/04/07	実	120,193	↑	+0.2%	-2.2%	9,337	↑	+0.4%	-12.7%	12,638	↑	+0.3%	-0.5%	9,658	↑	+3.8%	-2.4%
2022.02	2022/03/23	修正予	120,000	↓	-2.4%	-2.4%	9,300	↓	-13.1%	-13.1%	12,600	↓	-0.8%	-0.8%	9,300	↓	-6.1%	-6.1%
2022.02	2022/01/13	Q3予	122,900	→	0.0%	0.0%	10,700	→	0.0%	0.0%	12,700	→	0.0%	0.0%	9,900	→	0.0%	0.0%
2022.02	2021/10/14	Q2予	122,900	→	0.0%	0.0%	10,700	→	0.0%	0.0%	12,700	→	0.0%	0.0%	9,900	→	0.0%	0.0%
2022.02	2021/07/08	Q1予	122,900	→	0.0%	0.0%	10,700	→	0.0%	0.0%	12,700	→	0.0%	0.0%	9,900	→	0.0%	0.0%
2022.02	2021/04/08	当初予	122,900	-	-	-	10,700	-	-	-	12,700	-	-	-	9,900	-	-	-
2021.02	2021/04/08	実	114,510	↓	-0.4%	-9.8%	10,671	↑	+0.7%	-17.3%	11,829	↓	-0.6%	-20.1%	9,250	↓	-0.5%	-12.7%
2021.02	2021/03/23	修正予	115,000	↓	-9.4%	-9.4%	10,600	↓	-17.8%	-17.8%	11,900	↓	-19.6%	-19.6%	9,300	↓	-12.3%	-12.3%
2021.02	2021/01/13	Q3予	127,000	→	0.0%	0.0%	12,900	→	0.0%	0.0%	14,800	→	0.0%	0.0%	10,600	→	0.0%	0.0%
2021.02	2020/10/08	Q2予	127,000	→	0.0%	0.0%	12,900	→	0.0%	0.0%	14,800	→	0.0%	0.0%	10,600	→	0.0%	0.0%
2021.02	2020/07/09	当初予	127,000	-	-	-	12,900	-	-	-	14,800	-	-	-	10,600	-	-	-
2020.02	2020/04/10	実	140,992	↓	-1.7%	-1.7%	22,727	↓	-0.8%	-0.8%	25,628	↑	+0.5%	+0.5%	18,694	↓	-3.6%	-3.6%
2020.02	2020/01/10	Q3予	143,500	→	0.0%	0.0%	22,900	→	0.0%	0.0%	25,500	→	0.0%	0.0%	19,400	→	0.0%	0.0%
2020.02	2019/10/10	Q2予	143,500	→	0.0%	0.0%	22,900	→	0.0%	0.0%	25,500	→	0.0%	0.0%	19,400	→	0.0%	0.0%
2020.02	2019/07/10	Q1予	143,500	→	0.0%	0.0%	22,900	→	0.0%	0.0%	25,500	→	0.0%	0.0%	19,400	→	0.0%	0.0%
2020.02	2019/04/10	当初予	143,500	-	-	-	22,900	-	-	-	25,500	-	-	-	19,400	-	-	-
2019.02	2019/04/10	実	143,408	↓	-3.4%	-3.4%	22,278	↓	-7.2%	-7.2%	24,647	↓	-6.3%	-6.3%	19,204	↑	+0.0%	+0.0%
2019.02	2019/01/11	Q3予	148,500	→	0.0%	0.0%	24,000	→	0.0%	0.0%	26,300	→	0.0%	0.0%	19,200	→	0.0%	0.0%
2019.02	2018/10/10	Q2予	148,500	→	0.0%	0.0%	24,000	→	0.0%	0.0%	26,300	→	0.0%	0.0%	19,200	→	0.0%	0.0%
2019.02	2018/07/06	Q1予	148,500	→	0.0%	0.0%	24,000	-	-	-	26,300	→	0.0%	0.0%	19,200	→	0.0%	0.0%
2019.02	2018/04/10	当初予	148,500	-	-	-	-	-	-	-	26,300	-	-	-	19,200	-	-	-
2018.02	2018/04/10	実	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2018.02	2018/03/28	修正予	148,000	↑	+0.7%	+0.7%	-	-	-	-	28,400	↑	+10.9%	+10.9%	19,200	↑	+3.8%	+3.8%
2018.02	2018/01/12	Q3予	147,000	→	0.0%	0.0%	24,100	→	0.0%	0.0%	25,600	→	0.0%	0.0%	18,500	→	0.0%	0.0%
2018.02	2017/10/10	Q2予	147,000	→	0.0%	0.0%	24,100	→	0.0%	0.0%	25,600	→	0.0%	0.0%	18,500	→	0.0%	0.0%
2018.02	2017/07/07	Q1予	147,000	→	0.0%	0.0%	24,100	→	0.0%	0.0%	25,600	→	0.0%	0.0%	18,500	→	0.0%	0.0%
2018.02	2017/04/07	当初予	147,000	-	-	-	24,100	-	-	-	25,600	-	-	-	18,500	-	-	-
2017.02	2017/04/07	実	145,925	↓	-5.9%	-5.9%	26,306	↓	-6.1%	-6.1%	28,179	↓	-2.8%	-2.8%	20,395	↑	+5.1%	+5.1%
2017.02	2017/01/13	Q3予	155,000	→	0.0%	0.0%	28,000	→	0.0%	0.0%	29,000	→	0.0%	0.0%	19,400	→	0.0%	0.0%
2017.02	2016/10/11	Q2予	155,000	→	0.0%	0.0%	28,000	→	0.0%	0.0%	29,000	→	0.0%	0.0%	19,400	→	0.0%	0.0%
2017.02	2016/04/08	当初予	155,000	-	-	-	28,000	-	-	-	29,000	-	-	-	19,400	-	-	-
2016.02	2016/04/08	実	161,852	↓	-1.5%	-1.5%	27,730	↑	+1.2%	+1.2%	28,008	↓	-1.7%	-1.7%	17,784	↓	-2.8%	-2.8%
2016.02	2016/01/08	Q3予	164,300	→	0.0%	0.0%	27,400	→	0.0%	0.0%	28,500	→	0.0%	0.0%	18,300	→	0.0%	0.0%
2016.02	2015/10/09	Q2予	164,300	→	0.0%	0.0%	27,400	→	0.0%	0.0%	28,500	→	0.0%	0.0%	18,300	→	0.0%	0.0%
2016.02	2015/07/10	Q1予	164,300	→	0.0%	0.0%	27,400	-	-	-	28,500	→	0.0%	0.0%	18,300	→	0.0%	0.0%
2016.02	2015/04/08	当初予	164,300	-	-	-	-	-	-	-	28,500	-	-	-	18,300	-	-	-
2015.02	2015/04/08	実	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2015.02	2015/01/09	Q3予	161,900	→	0.0%	0.0%	20,400	→	0.0%	0.0%	27,800	→	0.0%	0.0%	18,000	→	0.0%	0.0%
2015.02	2014/10/09	Q2予	161,900	→	0.0%	0.0%	20,400	→	0.0%	0.0%	27,800	→	0.0%	0.0%	18,000	→	0.0%	0.0%
2015.02	2014/10/02	修正予	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2015.02	2014/07/10	Q1予	161,900	→	0.0%	0.0%	20,400	→	0.0%	0.0%	27,800	→	0.0%	0.0%	18,000	→	0.0%	0.0%
2015.02	2014/04/10	当初予	161,900	-	-	-	20,400	-	-	-	27,800	-	-	-	18,000	-	-	-
2014.02	2014/04/10	実	150,635	-	-	-	19,123	-	-	-	28,910	-	-	-	21,357	-	-	-

【4530】久光製薬 製薬。鎮痛消炎剤。大衆薬も。

業績予想修正履歴

【4530】久光製薬

製薬。鎮痛消炎剤。大衆薬も。